» Articles » PMID: 35280693

M2 Macrophage Derived Extracellular Vesicle-Mediated Transfer of MiR-186-5p Promotes Colon Cancer Progression by Targeting DLC1

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2022 Mar 14
PMID 35280693
Authors
Affiliations
Soon will be listed here.
Abstract

Colon cancer (CC) is one of the most common malignances in digestive tract. M2-polarized macrophages within the tumor microenvironment could facilitate CC cell growth by transferring molecules via extracellular vesicles, but the mechanisms are not fully elucidated. The current study aims to identify the possible effectors in M2 macrophage-derived extracellular vesicles (M2-EVs) and reveal related molecular mechanisms. In our study, we validated the promotion effects of M2-EVs on the proliferation and motility of CC cells, which was found to be dependent on the EVs enclosed molecules by a mild EVs digestion assay. Then we found that miR-186-5p was enriched in M2-EVs and was responsible for the tumor promoting functions of M2-EVs. Furthermore, mechanism investigation revealed M2-EVs transferring miR-186-5p inhibited DLC1 expression by targeting its 3'UTR, and restored DLC1 successfully neutralized the tumor-promoting effects of M2-EVs transferring miR-186-5p via inhibiting the β-catenin pathway. Our study revealed that M2-EVs facilitates the growth and motility of CC cells by delivering the enclosed miR-186-5p, which directly targets DLC1 mRNAs and facilitates their degradation, which could provide a potential biomarker and therapeutic target for CC.

Citing Articles

Prospect of extracellular vesicles in tumor immunotherapy.

Xia W, Tan Y, Liu Y, Xie N, Zhu H Front Immunol. 2025; 16:1525052.

PMID: 40078996 PMC: 11897508. DOI: 10.3389/fimmu.2025.1525052.


Systemic immune profiling analysis identifying M2-TAM related genes predicted colon cancer prognosis and chemotherapy responses.

Liu X, Liu D, Tan C, Wang J Medicine (Baltimore). 2025; 103(52):e40979.

PMID: 39969348 PMC: 11688056. DOI: 10.1097/MD.0000000000040979.


Macrophage-derived extracellular vesicles as new players in chronic non-communicable diseases.

Lin F, Luo H, Wang J, Li Q, Zha L Front Immunol. 2025; 15:1479330.

PMID: 39896803 PMC: 11782043. DOI: 10.3389/fimmu.2024.1479330.


Apoptotic breast cancer cells after chemotherapy induce pro-tumour extracellular vesicles via LAP-competent macrophages.

Zhang Q, Liu X, Wei Q, Xiong S, Luo W, Zhou Y Redox Biol. 2025; 80:103485.

PMID: 39756316 PMC: 11758215. DOI: 10.1016/j.redox.2024.103485.


Extracellular vesicles and macrophages in tumor microenvironment: Impact on cervical cancer.

Guo W, Liu W, Wang J, Fan X Heliyon. 2024; 10(15):e35063.

PMID: 39165926 PMC: 11334669. DOI: 10.1016/j.heliyon.2024.e35063.


References
1.
Wei L, Murphy B, Wu G, Parker M, Easton J, Gilbertson R . Exome sequencing analysis of murine medulloblastoma models identifies WDR11 as a potential tumor suppressor in Group 3 tumors. Oncotarget. 2017; 8(39):64685-64697. PMC: 5630286. DOI: 10.18632/oncotarget.19642. View

2.
Solomon D, Kim T, Diaz-Martinez L, Fair J, Elkahloun A, Harris B . Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science. 2011; 333(6045):1039-43. PMC: 3374335. DOI: 10.1126/science.1203619. View

3.
Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y . Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019; 21(4):498-510. DOI: 10.1038/s41556-019-0299-0. View

4.
Quail D, Joyce J . Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19(11):1423-37. PMC: 3954707. DOI: 10.1038/nm.3394. View

5.
Zhou C, Ma J, Huang L, Yi H, Zhang Y, Wu X . Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1. Oncogene. 2018; 38(8):1256-1268. PMC: 6363643. DOI: 10.1038/s41388-018-0511-x. View